Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares Ultra Energy
DIG
5
United Sts Brent Oil Fd Lp Unit
BNO
No Data
Karyopharm (KPTI) Leans on SENTRY in Pivotal Call
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Karyopharm Therapeutics Shares Are Trading Lower. The Company Reported Its Q1 Financial Results.
Leerink Partners Sticks to Its Hold Rating for Karyopharm Therapeutics (KPTI)
RBC Capital Maintains Karyopharm Therapeutics(KPTI.US) With Buy Rating, Maintains Target Price $16
RBC Capital Remains a Buy on Karyopharm Therapeutics (KPTI)